BioLineRx Ltd.（BLRX）· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。

FMP · BLRX · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income

Breakdown	2025-12	2024-12	2023-12	2022-12	2021-12
Revenue
Revenue	$1.19M	$28.94M	$4.80M	$0.00M	$0.00M
Cost of Revenue	$0.76M	$9.26M	$3.69M	$0.00M	$0.00M
Gross Profit	$0.43M	$19.68M	$1.11M	$0.00M	$0.00M
Gross Margin %(computed)	36.19%	67.99%	23.08%	—	—
Operating Expenses
R&D Expenses	$7.66M	$9.15M	$12.52M	$17.63M	$19.47M
G&A Expenses	$0.00M	$18.46M	$16.64M	$5.07M	$4.27M
Total Operating Expenses	$10.80M	$40.09M	$50.80M	$29.16M	$24.78M
Operating Income	($10.37M)	($20.41M)	($49.69M)	($29.16M)	($24.78M)
Operating Margin %(computed)	-871.78%	-70.52%	—	—	—
Interest Income	$1.13M	$1.83M	$2.01M	$0.69M	$0.56M
Interest Expense	$1.29M	$9.16M	$2.17M	$2.16M	$0.98M
Income Before Tax	($2.04M)	($9.22M)	($60.61M)	($24.95M)	($27.05M)
Income Tax Expense	$0.00M	$0.00M	$0.00M	$0.00M	$0.00M
Net Income	($1.18M)	($9.22M)	($60.61M)	($24.95M)	($27.05M)
Net Margin %(computed)	-99.58%	-31.86%	—	—	—
Per Share & EBITDA
EPS (Basic)	$-0.29	$-0.12	$-0.94	$-0.48	$-0.61
Wtd Avg Shares	4.11M	79.87M	64.22M	51.60M	44.20M
EBITDA	($9.84M)	$3.92M	($57.09M)	($28.50M)	($24.07M)
EBITDA Margin %(computed)	-827.46%	13.54%	—	—	—